Dr. Amer M. Alwreikat, MD

Dr. Alwreikat practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Alwreikat's NPI, 1215302146, was assigned on December 3, 2015. Dr. Alwreikat holds Massachusetts license 280942.

Dr. Alwreikat's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Alwreikat's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Dr. Alwreikat is also affiliated with Massachusetts General Hospital. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Alwreikat to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alwreikat practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Alwreikat's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Alwreikat is licensed in Massachusetts.

CMS data shows 2,924 Medicare services from Dr. Alwreikat across 18 procedure codes in 2024, for 836 Medicare patients. Medicare paid $264,690 for them.

CMS counts 836 Medicare patients who saw Dr. Alwreikat in 2024. The largest group is 75 to 84, with 418 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alwreikat's median patient age at 77, with 57% women.

In 2024, Dr. Alwreikat wrote 5,218 Medicare Part D claims for 973 patients. 75% of them were for generic drugs. CMS names the drug for 5,110 of them, across 22 drugs with 11 or more claims each, at $203,609 in total drug cost. In 2023, CMS named 4,526 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Alwreikat for performance year 2024, reported through an alternative payment model (APM). Dr. Alwreikat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alwreikat as offering telehealth. CMS counts 410 procedures of cataract surgery by Dr. Alwreikat, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Alwreikat, published from 2019 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Glaucoma, Open-Angle, Intraocular Pressure and Glaucoma. Dr. Alwreikat has published most often in Eye (Lond). Dr. Alwreikat's most frequent co-authors are Paul R. Cotran, MD, Shiyoung Roh, MD and Patrick Ross Aquino, MD.

CMS Open Payments shows 4 general payments to Dr. Alwreikat from 3 drug and device companies from 2019 to 2023. Consulting fees make up the largest share, 80% of the total. Beaver-Visitec International, Inc. paid the most, $650.